Avram E. Denburg

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

Cost-Effectiveness of Dabrafenib Plus Trametinib Versus Standard Chemotherapy in BRAFV600E-Mutant Pediatric Low-Grade Glioma.

Cost-Effectiveness of Dabrafenib Plus Trametinib Versus Standard Chemotherapy in BRAFV600E-Mutant Pediatric Low-Grade Glioma.

Journal: JCO oncology practice
Published: February 25, 2026

Understanding access to novel high-cost cancer therapies across Canada: a national survey of pediatric oncology providers.

Understanding access to novel high-cost cancer therapies across Canada: a national survey of pediatric oncology providers.

Journal: Frontiers in pediatrics
Published: January 21, 2026

Two cases of mosaic germline SVA insertions in SMARCB1: implications for rhabdoid tumour predisposition diagnosis.

Two cases of mosaic germline SVA insertions in SMARCB1: implications for rhabdoid tumour predisposition diagnosis.

Journal: NPJ genomic medicine
Published: December 24, 2025

The Patient-reported Genetic testing Utility InDEx (P-GUIDE): A novel measure of personal utility.

The Patient-reported Genetic testing Utility InDEx (P-GUIDE): A novel measure of personal utility.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: December 16, 2025

Pediatric Oncology Progress and Challenges in Southeast Asia: Strengthening Cancer Care Systems.

Pediatric Oncology Progress and Challenges in Southeast Asia: Strengthening Cancer Care Systems.

Journal: Pediatrics
Published: November 03, 2025

Considerations for Biosimilar Adoption in Pediatrics: A Scoping Review.

Considerations for Biosimilar Adoption in Pediatrics: A Scoping Review.

Journal: Pharmaceutical medicine
Published: October 16, 2025

Feasibility and clinical and implementation effectiveness of an adapted early warning signs and symptoms intervention for the early detection of childhood cancer in Cameroon and Kenya: protocol for a quasi-experimental, hybrid type 2 implementation effectiveness study.

Feasibility and clinical and implementation effectiveness of an adapted early warning signs and symptoms intervention for the early detection of childhood cancer in Cameroon and Kenya: protocol for a quasi-experimental, hybrid type 2 implementation effectiveness study.

Journal: BMJ open
Published: September 02, 2025

Income and employment outcomes in early adulthood among survivors of childhood cancer: a population-based longitudinal matched cohort study in Canada.

Income and employment outcomes in early adulthood among survivors of childhood cancer: a population-based longitudinal matched cohort study in Canada.

Journal: Journal of cancer survivorship : research and practice
Published: June 18, 2025

How We Approach the Integration of Psychological Services in the Care of Children With Cancer Predisposition Syndromes.

How We Approach the Integration of Psychological Services in the Care of Children With Cancer Predisposition Syndromes.

Journal: Pediatric blood & cancer
Published: May 30, 2025

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.

Journal: BMJ open
Published: May 30, 2025

How does personal utility depend on clinical setting? Evidence from 3 cohorts.

How does personal utility depend on clinical setting? Evidence from 3 cohorts.

Journal: Genetics in medicine open
Published: May 13, 2025

Forecasting Asparaginase Need and Cost for Childhood Cancer Using ACCESS FORxECAST.

Forecasting Asparaginase Need and Cost for Childhood Cancer Using ACCESS FORxECAST.

Journal: JCO global oncology
Published: January 30, 2025
Showing 1-12 of 83

Last Updated: 09/26/2026